General Atlantic, a global growth equity firm, has appointed Najat Khan as a senior advisor.

Khan brings over 10 years of operational and data science expertise in life sciences and will provide support to the firm’s investment teams and portfolio companies. Before General Atlantic, Khan served in leadership roles at Johnson & Johnson and chief data science officer and global head of strategy & operations at Janssen Research and Development where she reimagined the discovery and development of medicines across Janssen therapeutic areas.

“Najat is widely recognized as a global leader at the intersection of data science and the biological sciences,” added Brett Zbar, M.D., managing director and global head of life sciences at General Atlantic. “As we continue to partner with entrepreneurs who are leveraging technological innovation to reimagine the discovery and development of modern therapeutics, she will be a terrific asset to our investment team and our portfolio companies.”